|
10.03.2016 13:30:51
|
DGAP-News: Balda AG
DGAP-News: Balda AG: Stevanato Group takes over operating business
10.03.2016 / 13:30 The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Bad Oeynhausen, 10 March 2016 - After Balda AG had accepted the bid by Italian Stevanato Group on 4 February 2016 today the closing and transfer of ownership was carried out. Consequently, all operating units of the Balda Group and further assets have been transferred to the Stevanato Group. The operating business will continue to operate under the Balda name. Stevanato had handed in their binding offer in the amount of EUR 95 million on 29 January 2016 at the extraordinary general meeting and with it was able to win through the bidding war.
"Balda is considered an acclaimed plastics specialist, specifically in the area of medical technology, and possesses state-of-the-art production sites. We are very happy about our new Stevanato Group subsidiary and are envisioning outstanding growth potential - primarily in cooperation with our division Pharmaceutical Systems, operating under the brand Ompi", says Franco Stevanato, CEO of Stevanato Group.
The remaining holding will now change its name into Clere AG and will focus entirely on the realignment of the company. No revocatory action regarding the extraordinary general meeting has been received by the company. Thus the change of name as well as the registration of the capital decrease is expected to be carried out promptly.
"We are very pleased that the closing was conducted so swiftly and that the operating units are now an integral part of the family-run Stevanato Group. We are absolutely convinced that thereby Balda can most successfully be developed further", explains Oliver Oechsle, sole Management Board member of Balda AG and adds: "Now we can completely focus our attention on the remaining holding and dedicate ourselves to the elaboration of our new business model under the name of Clere AG."
Contact / Contact Person Michael Pfister Deekeling Arndt Advisors Tel: +49 (0) 5734 922 2555 Mobile: +49 (0) 160 90560506 Mail: michael.pfister@deekeling-arndt.de
About Stevanato Stevanato Group with its headquarters in Piombino Dese, Italy, was founded in 1949 and is specialized in the production of glass containers for pharmaceutical use, glass converting machines, visual inspection systems, assembling and packaging machines for the pharmaceutical industry. For instance, Stevanato Group is currently the market leader in the manufacture of cartridges for insulin pen injectors. With more than 2400 employees Stevanato Group generated a total of EUR 337,1 million in sales revenuesin 2015, of which 90 % are derived from export. Besides Italy, Stevanato is present with production plants in Denmark, Slovakia, Mexico and China. One plant is under contruction in Brazil and a sales office is present in US. www.stevanatogroup.com
About Balda After the sale of the operating business, the business model for the remaining Balda will lie with investments and shareholdings in the field of environmental and power engineering. Furthermore, the new Balda will pursue active asset management as well as SME business participations and SME financing. www.balda-group.com
---------------------------------------------------------------------------
10.03.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English Company: Balda AG Bergkirchener Str. 228 32549 Bad Oeynhausen Germany Phone: +49 (0) 57 34 / 9 22-0 Fax: +49 (0) 57 34 / 9 22-2604 E-mail: ir@balda-group.com Internet: www.balda-group.com ISIN: DE0005215107 WKN: 521510 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart End of News DGAP News Service ---------------------------------------------------------------------------
444167 10.03.2016
DGAP-News: Balda AG / Key word(s): Disposal Balda AG: Stevanato Group takes over operating business
10.03.2016 / 13:30 The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Bad Oeynhausen, 10 March 2016 - After Balda AG had accepted the bid by Italian Stevanato Group on 4 February 2016 today the closing and transfer of ownership was carried out. Consequently, all operating units of the Balda Group and further assets have been transferred to the Stevanato Group. The operating business will continue to operate under the Balda name. Stevanato had handed in their binding offer in the amount of EUR 95 million on 29 January 2016 at the extraordinary general meeting and with it was able to win through the bidding war.
"Balda is considered an acclaimed plastics specialist, specifically in the area of medical technology, and possesses state-of-the-art production sites. We are very happy about our new Stevanato Group subsidiary and are envisioning outstanding growth potential - primarily in cooperation with our division Pharmaceutical Systems, operating under the brand Ompi", says Franco Stevanato, CEO of Stevanato Group.
The remaining holding will now change its name into Clere AG and will focus entirely on the realignment of the company. No revocatory action regarding the extraordinary general meeting has been received by the company. Thus the change of name as well as the registration of the capital decrease is expected to be carried out promptly.
"We are very pleased that the closing was conducted so swiftly and that the operating units are now an integral part of the family-run Stevanato Group. We are absolutely convinced that thereby Balda can most successfully be developed further", explains Oliver Oechsle, sole Management Board member of Balda AG and adds: "Now we can completely focus our attention on the remaining holding and dedicate ourselves to the elaboration of our new business model under the name of Clere AG."
Contact / Contact Person Michael Pfister Deekeling Arndt Advisors Tel: +49 (0) 5734 922 2555 Mobile: +49 (0) 160 90560506 Mail: michael.pfister@deekeling-arndt.de
About Stevanato Stevanato Group with its headquarters in Piombino Dese, Italy, was founded in 1949 and is specialized in the production of glass containers for pharmaceutical use, glass converting machines, visual inspection systems, assembling and packaging machines for the pharmaceutical industry. For instance, Stevanato Group is currently the market leader in the manufacture of cartridges for insulin pen injectors. With more than 2400 employees Stevanato Group generated a total of EUR 337,1 million in sales revenuesin 2015, of which 90 % are derived from export. Besides Italy, Stevanato is present with production plants in Denmark, Slovakia, Mexico and China. One plant is under contruction in Brazil and a sales office is present in US. www.stevanatogroup.com
About Balda After the sale of the operating business, the business model for the remaining Balda will lie with investments and shareholdings in the field of environmental and power engineering. Furthermore, the new Balda will pursue active asset management as well as SME business participations and SME financing. www.balda-group.com
---------------------------------------------------------------------------
10.03.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English Company: Balda AG Bergkirchener Str. 228 32549 Bad Oeynhausen Germany Phone: +49 (0) 57 34 / 9 22-0 Fax: +49 (0) 57 34 / 9 22-2604 E-mail: ir@balda-group.com Internet: www.balda-group.com ISIN: DE0005215107 WKN: 521510 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart End of News DGAP News Service ---------------------------------------------------------------------------
444167 10.03.2016
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Clere (ex Balda)mehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu Clere (ex Balda)mehr Analysen
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.